Long-term protective effects of human recombinant nerve growth factor and monosialoganglioside GM1 treatment on primate nucleus basalis cholinergic neurons after neocortical infarction
- 1 April 1993
- journal article
- Published by Elsevier in Neuroscience
- Vol. 53 (3) , 625-637
- https://doi.org/10.1016/0306-4522(93)90611-i
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- Temporal changes in edema, Na+, K+, and Ca++ in focal cortical stroke: GM1 ganglioside reduces ischemic injuryJournal of Neuroscience Research, 1991
- Loss of nerve growth factor receptor-containing neurons in Alzheimer's disease: A quantitative analysis across subregions of the basal forebrainExperimental Neurology, 1989
- Neural plasticity of basal forebrain cholinergic neurons: effects of gangliosidesNeuroscience Letters, 1987
- Nerve growth factor action is mediated by cyclic AMP- and Ca+2/phospholipid-dependent protein kinases.The Journal of cell biology, 1986
- Nerve growth factor mRNA in brain: Localization by in situ hybridizationBiochemical and Biophysical Research Communications, 1986
- Ganglioside GM1 Does Not Initiate, but Enhances Neurite Regeneration of Nerve Growth Factor‐Dependent Sensory NeuronesJournal of Neurochemistry, 1985
- The basal nucleus of Meynert in patients with progressive supranuclear palsyNeuroscience Letters, 1984
- Gangliosides enhance neurite outgrowth in PC12 cellsDevelopmental Brain Research, 1983
- Interactions of GM1 Ganglioside with Crude Rat Brain Neuronal MembranesJournal of Neurochemistry, 1980
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976